Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Total Current Liabilities (2016 - 2026)

Mimedx's Total Current Liabilities history spans 17 years, with the latest figure at $44.6 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 4.53% to $44.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $44.6 million, a 4.53% increase, with the full-year FY2025 number at $64.3 million, up 40.95% from a year prior.
  • Total Current Liabilities hit $44.6 million in Q1 2026 for Mimedx, down from $64.3 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for MDXG hit a ceiling of $64.3 million in Q4 2025 and a floor of $36.6 million in Q1 2022.
  • Historically, Total Current Liabilities has averaged $45.1 million across 5 years, with a median of $43.6 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: crashed 33.96% in 2022 and later skyrocketed 40.95% in 2025.
  • Tracing MDXG's Total Current Liabilities over 5 years: stood at $43.6 million in 2022, then increased by 5.63% to $46.0 million in 2023, then fell by 0.9% to $45.6 million in 2024, then skyrocketed by 40.95% to $64.3 million in 2025, then plummeted by 30.68% to $44.6 million in 2026.
  • Business Quant data shows Total Current Liabilities for MDXG at $44.6 million in Q1 2026, $64.3 million in Q4 2025, and $57.7 million in Q3 2025.